A new report by the World Health Organization (WHO) and UNICEF says that 14.3 million children around the world have never received any vaccine
Browsing: Vaccine
Renowned virologist, Dr Simeon Agwale has hinted that Lassa fever vaccine produced by a Nigerian has scaled through preclinical trials involving mice and non-human primates.
A leading vaccine expert, Dr Simon Agwale, has called for urgent investment in vaccine research infrastructure to strengthen Nigeria’s ability to tackle future pandemics.
The Federal University Teaching Hospital (FUTH), Lafia, is set to lead the establishment of Nigeria’s first vaccine research and development hub focused on Lassa fever and other infectious outbreaks.
The Director-General of the National Biotechnology Research and Development Agency (NBRDA), Prof. Abdullahi Mustapha has called for synergy among various institutions engaged in vaccine research.
A Professor of Veterinary Public Health and Preventive Medicine, University of Ibadan, Prof. Simeon Cadmus has called for investment in vaccine and therapeutic research to mitigate the impact of Mpox in future outbreaks.
The World Health Organisation (WHO) has announced the addition of the MVA-BN vaccine to its prequalification list, marking the first vaccine against mpox to receive this designation.
A recent study from Ontario, Canada, has revealed that Bavarian Nordic A/S’s smallpox vaccine, marketed as Imvamune in Canada and Jynneos in the US, was 58% effective in preventing mpox infections after a single dose.
The AIDS Healthcare Foundation (AHF) has called for urgent global action to increase access to Mpox vaccines and prioritize public health over profits, emphasizing the importance of health security.
Philanthropist, Bill Gates, has highlighted the challenges associated with local vaccine production in Nigeria, citing regulatory complexities and economic scale as significant barriers.